Latest Supply Chain News

Black Cat Syndicate reports promising high-grade antimony drilling results at its Mt Clement project, confirming significant mineralisation within and beyond the current resource. The ongoing program aims to expand the resource and underpin economic studies for this critical minerals asset.

Lodestar Minerals has kicked off its first-ever exploration program at the Virgin Mountain Rare Earth Project in Arizona, targeting historically promising heavy and light rare earth elements amid shifting global supply dynamics.

Black Canyon Limited confirms high-grade manganese and iron mineralisation extending 1.8km south of its Wandanya discovery, bolstering the project's scale and potential ahead of planned drilling in 2026.

Dalrymple Bay Infrastructure has declared its Q3-25 distribution consistent with its full-year guidance, reinforcing its commitment to stable returns backed by its key coal export terminal.

K&S Corporation has issued a cautious earnings update, forecasting a significant decline in underlying profit before tax for the first half of 2025 compared to last year.

ABx Group has successfully raised over $6 million through a share placement to fund rapid development of its Deep Leads rare earth project and ALCORE pilot plant in Tasmania.

Renascor Resources has hit key construction milestones at its Australian Government co-funded Purified Spherical Graphite (PSG) demonstration facility, maintaining schedule for on-site commissioning this quarter. The project aims to establish a competitive, HF-free PSG supply chain outside China.

Trigg Minerals has revealed a significant northern extension of high-grade antimony mineralisation at its Antimony Canyon Project in Utah, confirming bonanza-grade continuity and validating its exploration model.

Mount Ridley Mines has identified seven new high-priority rare earth and gallium target zones forming a 33km untested corridor near existing resources in Western Australia, setting the stage for significant exploration expansion.

Mesoblast has achieved a landmark FDA approval for RYONCIL, the first allogeneic mesenchymal stromal cell therapy, driving strong commercial momentum and advancing a robust pipeline targeting inflammatory diseases.

Fulcrum Lithium reports encouraging initial metallurgical results from its Alkali Flats project in Nevada, showing up to 91% lithium recovery at moderate conditions, setting the stage for further exploration and resource definition.

Clarity Pharmaceuticals has raised $203 million to accelerate its copper-64 and copper-67 radiopharmaceutical pipeline, targeting prostate and neuroendocrine cancers with multiple FDA Fast Track trials underway.